BlackRock Health Sciences Term Trust $BMEZ Stock Holdings Raised by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. grew its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 96.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 197,033 shares of the company’s stock after buying an additional 96,920 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $3,290,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in BMEZ. SouthState Bank Corp bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $29,000. PNC Financial Services Group Inc. purchased a new stake in BlackRock Health Sciences Term Trust during the 1st quarter valued at $35,000. Integrated Wealth Concepts LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth $46,000. Fifth Third Bancorp bought a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth $142,000. Finally, Kingswood Wealth Advisors LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 16.8% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 12,278 shares of the company’s stock worth $205,000 after purchasing an additional 1,762 shares in the last quarter.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock opened at $17.54 on Friday. BlackRock Health Sciences Term Trust has a 1-year low of $13.70 and a 1-year high of $17.96. The business has a fifty day moving average price of $16.74 and a 200-day moving average price of $15.32.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be issued a $0.11 dividend. This represents a $1.32 annualized dividend and a yield of 7.5%. The ex-dividend date is Friday, December 11th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end investment fund managed by BlackRock Advisors. The fund seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity securities of companies involved in the health sciences sector.

Its investment universe may include biotechnology, pharmaceuticals, medical devices, health-care services, life sciences tools and related businesses. The portfolio can hold investments in companies across different stages of development and in multiple countries, giving shareholders exposure to global health-care innovation and research.

BlackRock Health Sciences Term Trust is structured as a term trust, meaning it was established with a planned termination date, subject to applicable shareholder and board actions.